Abstract
Background: The aim of this study was to determine the prognostic value of the cyclindependent kinase inhibitors, p21 Waf1/CiP1 and p27Kip1, and the cell cycle regulating proteins cyclin D1 and p53 after curative surgery for rectal cancer. Methods: Formalin-fixed, paraffin- embedded tissue samples of 160 rectal carcinomas resected curatively within a 5-year period were used. Immunohistochemical analysis was performed using monoclonal antibodies: p21Waf1/Cip1 (clone SX118), p27Kip1 (clone SX53G8), cyclin D1 (clone DCS-6) and p53 (DO-1). Positive nuclear protein expression was assessed at the 10% level. Results of immunohistochemistry were correlated with clinical and histopathologic data of the prospective tumor registry, including recurrence and patient survival. Statistics included univariate and multivariate analysis (p < 0.05 statistically significant), and survival was calculated using the Kaplan-Meier method. Results: Of the 160 rectal carcinomas, 36% (57/160) were p21Waf1/Cip1-positive, 44% (70/160) were p27Kip1-positive, 48% (76/160) were cyclin D1-positive, and 39% (63/160) were p53-positive. p21Waf1/Cip1 staining pattern correlated with p27Kp1 and p53 expression (p < 0.05). p21Waf1/Cip1 was also associated with UICC stage and lymph node status (p < 0.05). p53 status was not correlated with any clinical or histopathologic variable (p < 0.05). p27Kip1 expression was associated with tumor size and cyclin D1 expression (p < 0.05). Tumor progression caused by local and distant recurrence occurred in 20% (n = 32). p21Waf1/Cip1 ,p27Kip1 and P53 were strong predictors of recurrence, both in univariate and multivariate analysis. Furthermore, p21Waf1/Cip1 and p53 but not p27Kip1 were independently correlated with disease-free survival. Clinically, UICC stage was independently related to both recurrence and survival. Best prognosis was related to p21Waf1/Cip1-positive and p53-negative rectal carcinomas. Conclusions: Reflecting tumor biology by immunohistochemical assessment of cell cycle regulators, p21Waf1/Cip1 and p53 were independently predictive of prognosis in rectal cancer, and p27Kip1 was independently related to recurrence. However, cyclin Di had no independent relationship to prognosis. Clinically, UICC stage was a strong predictor of both recurrence and survival after curative surgery for rectal cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Hermanek P (1999) Impact of surgeon’s technique on outcome after treatment of rectal carcinoma. Dis Colon Rectum 42: 559–562
Heald RJ (1995) Total mesorectal excision is optimal surgery for rectal cancer: a Scandinavian consensus. Br J Surg 82:1297–1299
Ky AJ, Sung MW, Milsom JW (1999) Research in colon and rectal cancer with emphasis on surgical progress. Dis Colon Rectum 42:1369–1380
Cheng JD, Werness BA, Babb JS, Meropol NJ (1999)Paradoxical correlations of cyclin-dependent kinase inhibitors p2iwafi/cipi and p2/kipi in metastatic colorectal carcinoma. Clin Cancer Res 5:1057–1062
McKay JA, Douglas JJ, Ross VG, Curran S, Ahmed FY, Loane JF, Murray GI, McLeod HL (2000) Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases. Clin Cancer Res 6: 1113–1118
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Schwandner, O., Bruch, HP., Broll, R. (2001). p21, p27, Cyclin D1 und p53 beim Rektumkarzinom: Immunhistologie mit prognostischer Relevanz?. In: Schönleben, K., Neugebauer, E., Hartel, W., Menger, M.D. (eds) Chirurgisches Forum 2001 für experimentelle und klinische Forschung. Deutsche Gesellschaft für Chirurgie, vol 30. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56698-1_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-56698-1_27
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-41718-7
Online ISBN: 978-3-642-56698-1
eBook Packages: Springer Book Archive